Context Therapeutics Inc. (CNTX) Q1 2024 Earnings
CNTX·Reported May 8, 2024·Before market open
Diluted EPS came in at $-0.23, beat the $-0.38 consensus by $0.15.
Diluted EPS
$-0.23beat by $0.15
Consensus: $-0.38
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Context Therapeutics Inc.'s Q1 2024 earnings report.
Context Therapeutics Inc. (CNTX) reported Q1 2024 earnings on May 8, 2024 before market open.
Context Therapeutics Inc. reported diluted EPS of $-0.23 for Q1 2024.
EPS beat the consensus estimate of $-0.38 by $0.15.
You can read the 10-Q periodic report (0001842952-24-000035) directly on SEC EDGAR. The filing index links above go to sec.gov.